Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer.
Feliu J, Martín G, Madroñal C, Rodríguez-Jaráiz A, Castro J, Rodríguez A, Checa T, Bolaño M, Casado E, González-Barón M. Feliu J, et al. Among authors: casado e. Cancer Chemother Pharmacol. 2003 Sep;52(3):247-52. doi: 10.1007/s00280-003-0638-4. Epub 2003 May 29. Cancer Chemother Pharmacol. 2003. PMID: 12783203 Clinical Trial.
New insights in beta-tubulin sequence analysis in non-small cell lung cancer.
de Castro J, Belda-Iniesta C, Cejas P, Casado E, Fresno Vara JA, Hardisson D, Sánchez JJ, Feliu J, Ordóñez A, Nistal M, González-Barón M. de Castro J, et al. Among authors: casado e. Lung Cancer. 2003 Jul;41(1):41-8. doi: 10.1016/s0169-5002(03)00123-5. Lung Cancer. 2003. PMID: 12826311 Clinical Trial.
Doomed trials for promising adenoviruses: a rationale for success.
Casado E, De Castro J, Belda-Iniesta C, Feliu J, González-Barón M, Arafat W. Casado E, et al. J Clin Oncol. 2004 Mar 15;22(6):1162-3; author reply 1163-4. doi: 10.1200/JCO.2004.99.235. J Clin Oncol. 2004. PMID: 15020624 No abstract available.
PI3K/Akt signalling pathway and cancer.
Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, González-Barón M. Fresno Vara JA, et al. Among authors: casado e. Cancer Treat Rev. 2004 Apr;30(2):193-204. doi: 10.1016/j.ctrv.2003.07.007. Cancer Treat Rev. 2004. PMID: 15023437 Review.
Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain).
Cejas P, Casado E, Belda-Iniesta C, De Castro J, Espinosa E, Redondo A, Sereno M, García-Cabezas MA, Vara JA, Domínguez-Cáceres A, Perona R, González-Barón M. Cejas P, et al. Among authors: casado e. Cancer Causes Control. 2004 Sep;15(7):707-19. doi: 10.1023/B:CACO.0000036189.61607.52. Cancer Causes Control. 2004. PMID: 15280629 Review.
Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma.
De Castro J, Lorenzo A, Morales S, Belón J, Dorta J, Lizón J, Madroñal C, Gallurt PM, Casado E, Feliu J, Barón MG; Oncopaz Cooperative Group. De Castro J, et al. Among authors: casado e. Cancer Chemother Pharmacol. 2005 Feb;55(2):197-202. doi: 10.1007/s00280-004-0869-z. Epub 2004 Aug 21. Cancer Chemother Pharmacol. 2005. PMID: 15322824 Clinical Trial.
184 results